Apolipoprotein E mimetics and cholesterol-lowering properties. - Wikidata - wikimedia - TriplyDB

Apolipoprotein E mimetics and cholesterol-lowering properties.

Apolipoprotein E mimetics and cholesterol-lowering properties.

http://www.wikidata.org/entity/Q37965590

about

Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome.A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats New genes and new insights from old genes: update on Alzheimer disease.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.High-density lipoprotein mimetics: promises and challenges.When the dust settles: what did we learn from the bexarotene discussion?The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.

P2860

Q33813945-41733196-E22F-4B23-A5C9-004806C41F30 Q33995580-BEF27AA3-9491-4634-AE1E-CC418A945DEE Q34238630-A094D92E-C2E7-4513-86A2-44DED07310E4 Q35927509-53575082-8465-4E3C-A386-21CECA170DD9 Q35974993-F8B705ED-347F-45C7-B921-6FA4E3184520 Q36282246-7005B316-508A-4FD7-827E-5BAC86E2148D Q36302783-BA469FB7-64B8-4190-A674-F1E47B696182 Q37228000-00F80EF9-00D1-4B59-9A45-4904E282EF54 Q37401827-E8FFCDC9-31F4-4E25-924B-C6F3B5C36871 Q37560444-1D62C5E0-B5D0-4AE0-B23C-5C1F93DA377A Q37671683-CAE059B7-604F-4F7C-AB3A-4D21E176D429 Q38089692-BB8E9710-32C1-41E4-A40A-8B0ACC249674 Q38650575-CFC84976-9761-40D4-B709-E8A25B21A201 Q38651786-39978733-5941-47E6-AA84-70B96EB5D213 Q38767234-40C03DD9-AC9E-40C8-ACD6-CEC274580C74 Q39045016-1402BF12-C1AF-415D-8AC0-5C66943C236B Q47125219-60636BBC-14FF-400C-8B6F-2A5CD17AFBBD

P2860

Apolipoprotein E mimetics and cholesterol-lowering properties.

http://www.wikidata.org/entity/Q37965590

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Apolipoprotein E mimetics and cholesterol-lowering properties.

@en

Apolipoprotein E mimetics and cholesterol-lowering properties.

@nl

type

label

Apolipoprotein E mimetics and cholesterol-lowering properties.

@en

Apolipoprotein E mimetics and cholesterol-lowering properties.

@nl

prefLabel

Apolipoprotein E mimetics and cholesterol-lowering properties.

@en

Apolipoprotein E mimetics and cholesterol-lowering properties.

@nl

P1433

Q37965590-6E7FA951-D5EE-45BC-A7ED-F468C72CBCBE

P1476

Q37965590-D47D56BD-CF8D-4017-8A6D-622AF1A1FFC0

P2093

Q37965590-0A874C95-64B3-4A42-8EC3-C6304FF6BEB6

Q37965590-1FD03458-6597-404D-B501-205FD1CC127A

Q37965590-25E8445F-5658-401C-B3CD-183C07DC9FF4

Q37965590-28E4206A-EEB1-4F9A-998A-A6E04A7F407A

Q37965590-3E80123D-0AEB-4BB1-AD41-A412DA9C42C2

Q37965590-904388A8-7BA4-49C4-BA07-3327B2E90365

Q37965590-A6410818-8A34-495C-99B1-F7B0CB036329

Q37965590-DF97E8CA-1FA1-482A-8F33-27BE4235EB3B

P2860

Q37965590-01E734ED-6A8B-4672-B160-8941B179FAA5

Q37965590-0E0018ED-4B39-41AF-9F51-BD28F9A45282

Q37965590-0FC94E85-4413-4C68-B383-446F689E461F

Q37965590-16AAC5A3-D4CB-43C7-BBE1-B2C2D7793B81

Q37965590-1E95EE31-17A7-4B12-ACDB-D6C8C2AFC13F

Q37965590-22E933E5-C573-4CED-8313-00FE7EEE734B

Q37965590-23BF4892-1768-4E12-B265-7CE9B47C983C

Q37965590-2A65888D-C478-4663-AEDB-1B5BC020D0E7

Q37965590-36979DD4-EEE9-4347-ABAE-3DD70106DA82

Q37965590-39053FC9-EDA6-4CAB-98F5-0C0464B65C10

P2888

Q37965590-9C62D272-BF86-452A-8476-28AFC013C2D9

P304

Q37965590-4C3F6339-37BC-4DA6-9C01-F07541001392

P31

Q37965590-8BC42650-B268-4B44-889E-B4E004E0E4EB

P356

Q37965590-B1CB9B9C-C036-4CD3-A447-63689BF440C8

P433

Q37965590-3F558AC4-31E4-4FE2-9ADF-FC1C2E86489B

P478

Q37965590-7F90B0B5-5CE4-41D5-A384-5FDF619EB06C

P577

Q37965590-AACD2ECC-B403-4164-86B9-572836521BD7

P5875

Q37965590-4C6F86B4-325C-4671-876D-CC24D7EBA2A2

P6179

Q37965590-2DE55821-44AA-494A-BF4B-CFF07D4325D3

P698

Q37965590-E7CBD030-5BB3-4AEC-A14E-9C2C86C0FE6C

P356

11594190-000000000-00000

P1433

American journal of cardiovascular drugs

P1476

Apolipoprotein E mimetics and cholesterol-lowering properties.

@en

P2093

David W Garber

http://www.w3.org/2001/XMLSchema#string

Dennis Goldberg

http://www.w3.org/2001/XMLSchema#string

G M Anantharamaiah

http://www.w3.org/2001/XMLSchema#string

Gaurav Nayyar

http://www.w3.org/2001/XMLSchema#string

Himanshu Gupta

http://www.w3.org/2001/XMLSchema#string

Oleg F Sharifov

http://www.w3.org/2001/XMLSchema#string

Shaila P Handattu

http://www.w3.org/2001/XMLSchema#string

Vinod K Mishra

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Apolipoprotein E: far more than a lipid transport protein

Apolipoprotein E: possible therapeutic target for atherosclerosis

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

P2888

11594190-000000000-00000

P304

371-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11594190-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51859800

http://www.w3.org/2001/XMLSchema#string

P6179

1003120019

http://www.w3.org/2001/XMLSchema#string

P698

22149316

http://www.w3.org/2001/XMLSchema#string